TVI-Brain-1
- Generic Name
- TVI-Brain-1
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Associated Conditions
- -
- Associated Therapies
- -
Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-01-13
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- TVAX Biomedical
- Target Recruit Count
- 120
- Registration Number
- NCT05685004
- Locations
- 🇺🇸
Center for Neurosciences, Tucson, Arizona, United States
🇺🇸Providence St. Vincent, Portland, Oregon, United States
🇺🇸Cedar-Sanai Medical Center, Los Angeles, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath